IN8bio Decline After Favorable Leukemia Results Could Be Profit-Taking -- Market Talk
IN8bio Decline After Favorable Leukemia Results Could Be Profit-Taking -- Market Talk
在有利的白血病结果之后,in8bio股价走低可能是获利了结--市场评论
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册